— Know what they know.
Not Investment Advice

BVS NASDAQ

Bioventus Inc.
1W: -10.6% 1M: -2.9% 3M: +10.6% YTD: +31.6% 1Y: +35.8% 3Y: +690.8% 5Y: -40.1%
$9.28
-0.21 (-2.26%)
After Hours: $9.49 (+0.21, +2.26%)
Weekly Expected Move ±6.1%
$9 $10 $11 $11 $12
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Sell · Power 44 · $628.7M mcap · 47M float · 0.988% daily turnover · Short 66% of daily vol

📊 Key Metrics

TTM
$576M
Revenue
+1.5% YoY
$28M
Net Income
+185.5% YoY
$101M
Free Cash Flow
+320.5% YoY
67.9%
Gross Margin
6.7%
Op. Margin
2.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE17.2%
ROA4.0%
ROIC14.1%

Valuation

P/E22.1
P/B3.3
EV/EBITDA8.4

Leverage

Debt/Equity1.69
Current Ratio1.70
Interest Cov.2.5x

Quality Scores

Piotroski F7/9
Altman Z1.47
Beneish M-3.02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms